Cite
MLA Citation
Yoon‐Sim Yap et al.. “Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer.” Cancer science, vol. 111, no. 9, 2020, pp. 3313–3326. http://access.bl.uk/ark:/81055/vdc_100107633478.0x00002c